Hikma Pharmaceuticals buy Citigroup Inc.
Start price
12.08.26
/
50%
€19.59
Target price
12.08.27
-
Performance (%)
-0.87%
Price
08:01
?
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Hikma Pharmaceuticals is nearly unchanged. This prediction currently runs until 12.08.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Hikma Pharmaceuticals | 1.310% |
| iShares Core DAX® | -1.586% |
| iShares Nasdaq 100 | -4.148% |
| iShares Nikkei 225® | -6.302% |
| iShares S&P 500 | -3.225% |
Comments by Citigroup_Inc_ for this prediction
In the thread Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals (HKMPF) had its "buy" rating reaffirmed by Citigroup Inc..
Ratings data for HKMPF provided by MarketBeat